Does HYALURONIDASE Cause Mobility decreased? 255 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 255 reports of Mobility decreased have been filed in association with HYALURONIDASE (Phesgo). This represents 23.0% of all adverse event reports for HYALURONIDASE.
255
Reports of Mobility decreased with HYALURONIDASE
23.0%
of all HYALURONIDASE reports
208
Deaths
240
Hospitalizations
How Dangerous Is Mobility decreased From HYALURONIDASE?
Of the 255 reports, 208 (81.6%) resulted in death, 240 (94.1%) required hospitalization, and 238 (93.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE. However, 255 reports have been filed with the FAERS database.
What Other Side Effects Does HYALURONIDASE Cause?
Fatigue (375)
Alopecia (358)
Abdominal discomfort (355)
Arthralgia (349)
Diarrhoea (330)
Headache (328)
Hypertension (325)
Blood cholesterol increased (320)
Arthropathy (318)
Off label use (315)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which HYALURONIDASE Alternatives Have Lower Mobility decreased Risk?
HYALURONIDASE vs HYALURONIDASE-OCSQ\OCRELIZUMAB
HYALURONIDASE vs HYALURONIDASE \RITUXIMAB
HYALURONIDASE vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB
HYALURONIDASE vs HYDRALAZINE
HYALURONIDASE vs HYDRALAZINE\ISOSORBIDE DINITRATE